[1] Ascherio A, Schwarzschild MA. The epidemiology of Parkinson's disease:risk factors and prevention[J]. Lancet Neurol, 2016, 15:1257-1272.
[2] Raza C, Anjum R, Shakeel NU. Parkinson's disease:mechanisms, translational models and management strategies[J]. Life Sci, 2019, 226:77-90.
[3] Wang YR, Zhang SS, Li J. Advances in MRI studies of Parkinson's disease with anxiety[J]. Zhongguo Xian Dai Shen Jing Ji Bing Za Zhi, 2019, 19:443-447.[王艺蓉, 张树山, 李健.帕金森病伴焦虑的磁共振成像研究进展[J]. 中国现代神经疾病杂志, 2019, 19:443-447.]
[4] Zhang Z, Chen SD. Research progress of autonomic dysfunction in Parkinson's disease[J]. Zhongguo Xian Dai Shen Jing Ji Bing Za Zhi, 2019, 19:367-373.[张哲, 陈生弟. 帕金森病自主神经功能障碍研究进展[J]. 中国现代神经疾病杂志, 2019, 19:367-373.]
[5] Schrag A, Taddei RN. Depression and anxiety in Parkinson's disease[J]. Int Rev Neurobiol, 2017, 133:623-655.
[6] Schindlbeck KA, Lucas-Jiménez O, Tang CC, Morbelli S, Arnaldi D, Pardini M, Pagani M, Ibarretxe-Bilbao N, Ojeda N, Nobili F, Eidelberg D. Metabolic network abnormalities in drug-naive Parkinson's disease[J]. Mov Disord, 2020, 35:587-594.
[7] Kim R, Kim HJ, Shin C, Park H, Kim A, Paek SH, Jeon B. Long-term effect of subthalamic nucleus deep brain stimulation on freezing of gait in Parkinson's disease[J]. J Neurosurg, 2019, 131:1797-1804.
[8] Hitti FL, Ramayya AG, McShane BJ, Yang AI, Vaughan KA, Baltuch GH. Long-term outcomes following deep brain stimulation for Parkinson's disease[J]. J Neurosurg, 2019, 18:1-6.
[9] Philipson J, Blomstedt P, Fredricks A, Hariz M, Stenmark Persson R, Jahanshahi M. Short- and long-term cognitive effects of deep brain stimulation in the caudal zona incerta versus best medical treatment in patients with Parkinson's disease[J]. J Neurosurg, 2020.[Epub ahead of print]
[10] Odekerken VJ, Boel JA, Schmand BA, de Haan RJ, Figee M, van den Munckhof P, Schuurman PR, de Bie RM; NSTAPS study group. GPi vs STN deep brain stimulation for Parkinson disease:three-year follow-up[J]. Neurology, 2016, 86:755-761.
[11] Blasberg F, Wojtecki L, Elben S, Slotty PJ, Vesper J, Schnitzler A, Groiss SJ. Comparison of awake vs. asleep surgery for subthalamicdeep brain stimulation in Parkinson's disease[J]. Neuromodulation, 2018, 21:541-547.
[12] Hagelweide K, Schö nberger AR, Kracht LW, Gründler TO, Fink GR, Schubotz RI. Motor cognition in patients treated with subthalamicnucleus deep brain stimulation:limits of compensatory overactivity in Parkinson's disease[J]. Neuropsychologia, 2018, 117:491-499.
[13] Wang J, Ponce FA, Tao J, Yu HM, Liu JY, Wang YJ, Luan GM, Ou SW. Comparison of awake and asleep deep brain stimulation for Parkinson's disease:adetailed analysis through literature review[J]. Neuromodulation, 2020, 23:444-450.
[14] Ho AL, Ali R, Connolly ID, Henderson JM, Dhall R, Stein SC, Halpern CH. Awake versus asleep deep brain stimulation for Parkinson's disease:a critical comparison and meta-analysis[J]. J Neurol Neurosurg Psychiatry, 2018, 89:687-691.
[15] Liu JY, Lü H, Tang RR, Yu HM, Ren Y, Ou SW, Pei L, Wang YJ, Wang J. Analysis of intra-operativetarget location of subthalamic nucleusin deep brain stimulation surgery for Parkinson's disease withbispectral index monitoring under general anesthesia[J]. Zhonghua Shen Jing Wai Ke Za Zhi, 2019, 35:1011-1014.[刘济源, 吕红, 汤如荣, 禹红梅, 任艳, 欧绍武, 裴凌, 王运杰, 王军. 全身麻醉脑电双频指数监测下丘脑底核脑深部电刺激术治疗帕金森病靶点定位分析[J]. 中华神经外科杂志, 2019, 35:1011-1014.]
[16] Parkinson's Disease and Movement Disorders Group of the Chinese Medical Association Neurology Branch, Parkinson's Disease and Movement Disorders Specialty of the Chinese Medical Doctor Association Neurologist Branch. Chinese Parkinson's disease diagnostic criteria (2016 edition)[J]. Zhonghua Shen Jing Ke Za Zhi, 2016, 49:268-271.[中华医学会神经病学分会帕金森病及运动障碍学组, 中国医师协会神经内科医师分会帕金森病及运动障碍专业. 中国帕金森病的诊断标准(2016版)[J]. 中华神经科杂志, 2016, 49:268-271.]
[17] Matias CM, Frizon LA, Nagel SJ, Lobel DA, Machado AG. Deep brain stimulation outcomes in patients implanted under general anesthesia with frame-based stereotaxy and intraoperative MRI[J]. J Neurosurg, 2018, 129:1572-1578.
[18] Geevarghese R, O'Gorman Tuura R, Lumsden DE, Samuel M, Ashkan K. Registration accuracy of CT/MRI fusion for localisation of deep brain stimulation electrode position:an imaging study and systematic review[J]. Stereotact Funct Neurosurg, 2016, 94:159-163.
[19] Su XL, Luo XG, Lü H, Wang J, Ren Y, He ZY. Factors predicting the instant effect of motor function after subthalamic nucleus deep brain stimulation in Parkinson's disease[J]. Transl Neurodegener, 2017, 6:14.
[20] Chen T, Mirzadeh Z, Chapple KM, Lambert M, Shill HA, Moguel-Cobos G, Tröster AI, Dhall R, Ponce FA. Clinical outcomes following awake and asleep deep brain stimulation for Parkinson disease[J]. J Neurosurg, 2018, 130:109-120.
[21] Mirzadeh Z, Chapple K, Lambert M, Evidente VG, Mahant P, Ospina MC, Samanta J, Moguel-Cobos G, Salins N, Lieberman A, Tröster AI, Dhall R, Ponce FA. Parkinson's disease outcomes after intraoperative CT-guided "asleep" deep brain stimulation in the globus pallidus internus[J]. J Neurosurg, 2016, 124:902-907.
[22] Ostrem JL, Ziman N, Galifianakis NB, Starr PA, Luciano MS, Katz M, Racine CA, Martin AJ, Markun LC, Larson PS. Clinical outcomes using clearpoint interventional MRI for deep brain stimulation lead placement in Parkinson's disease[J]. J Neurosurg, 2016, 124:908-916.
[23] Kogan M, McGuire M, Riley J. Deep brain stimulation for Parkinson disease[J]. Neurosurg Clin N Am, 2019, 30:137-146.
[24] Limousin P, Foltynie T. Long-term outcomes of deep brain stimulation in Parkinson disease[J]. Nat Rev Neurol, 2019, 15:234-242.
[25] Karl JA, Ouyang B, Colletta K, Verhagen Metman L. Long-term satisfaction and patient-centered outcomes of deep brain stimulation in Parkinson's disease[J]. Brain Sci, 2018, 8:60.
[26] Park KW, Jo S, Kim MS, Choi N, Jeon SR, Park HK, Kwon KY, Lee CS, Chung SJ. Cognitive profile as a predictor of the long-term outcome after deep brain stimulation in Parkinson's disease[J]. J Neurol Sci, 2020, 417:117063.
[27] Kim MS, Ryu HS, Park KW, Choi N, You S, Kim MJ, Kim YJ, Kim J, Kim K, Chung SJ. Age-dependent efficacy of subthalamic nucleus deep brain stimulation in young- and late-onset Parkinson's disease based on a 10 year follow-up[J]. J Neurol Sci, 2020, 416:117004.
[28] Hacker ML, Turchan M, Heusinkveld LE, Currie AD, Millan SH, Molinari AL, Konrad PE, Davis TL, Phibbs FT, Hedera P, Cannard KR, Wang L, Charles D. Deep brain stimulation in early-stage Parkinson disease:five-year outcomes[J]. Neurology, 2020, 95:e393-401.
[29] Evered LA, Silbert BS. Postoperative cognitive dysfunction and noncardiacsurgery[J]. Anesth Analg, 2018, 127:496-505.
[30] Combs HL, Folley BS, Berry DT, Segerstrom SC, Han DY, Anderson-Mooney AJ, Walls BD, van Horne C. Cognition and depression following deep brain stimulation of the subthalamicnucleus and globuspallidus pars internus in Parkinson's disease:a Meta-analysis[J]. Neuropsychol Rev, 2015, 25:439-454.
[31] Nir T, Jacob Y, Huang KH, Schwartz AE, Brallier JW, Ahn H, Kundu P, Tang CY, Delman BN, McCormick PJ, Sano M, Deiner S, Baxter MG, Mincer JS. Resting-state functional connectivity in early postanaesthesia recovery is characterised by globally reduced anticorrelations[J]. Br J Anaesth, 2020, 125:529-538.
[32] Fluchere F, Witjas T, Eusebio A, Bruder N, Giorgi R, Leveque M, Peragut JC, Azulay JP, Regis J. Controlled general anaesthesia for subthalamic nucleus stimulation in Parkinson's disease[J]. J Neurol Neurosurg Psychiatry, 2014, 85:1167-1173. |